Loading…
Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature
Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently publishe...
Saved in:
Published in: | Acta histochemica 2019-08, Vol.121 (6), p.765-767 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923 |
---|---|
cites | cdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923 |
container_end_page | 767 |
container_issue | 6 |
container_start_page | 765 |
container_title | Acta histochemica |
container_volume | 121 |
creator | Ricci, Costantino Dika, Emi Di Nanni, Doriana Donatella Zannetti, Guido Lambertini, Martina Corti, Barbara |
description | Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis. |
doi_str_mv | 10.1016/j.acthis.2019.06.002 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2246242349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0065128119300947</els_id><sourcerecordid>2246242349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</originalsourceid><addsrcrecordid>eNp9UcuO1DAQjBCIHRb-AKE-cklo23nMXECj0fKQFnGBs9VxOoyHJJ61nUX7c3wbzmbZI6dWuavcXV1Z9lpgIVDU704FmXi0oZAodgXWBaJ8km1ELbY5qkY-zTaIdZULuRUX2YsQToi4QyWfZxdKSIUNVpvsz8HNQwdXX_dAUwfmLrpf7CnaCRpoGebA_TxAgp0N6fXnbMMxFYjemqMbeBxpAEPe2MmNBL13I5iByeeGhwHCzUyjmwPco0feB9gnEBgCe8thlbnZQ8dn8nHkKd7vQ9Cmfg-eby3_BtdDPDIMNi47zp5fZs96GgK_eqiX2Y-PV98Pn_Prb5--HPbXuVG1jDm3omJMZ1OmKuueVCtMXTeNIqxIKdwJllvGVkrTERvVSUNIZJYO8U6qy-zt-u_Zu5uZQ9SjDYslmji501KWtSylKneJWq5U410Innt99nYkf6cF6iU5fdJrcnpJTmOtU3JJ9uZhwtyO3D2K_kWVCO9XAief6RpeB2N5MtxZzybqztn_T_gLfHOveA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2246242349</pqid></control><display><type>article</type><title>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</title><source>ScienceDirect Journals</source><creator>Ricci, Costantino ; Dika, Emi ; Di Nanni, Doriana Donatella ; Zannetti, Guido ; Lambertini, Martina ; Corti, Barbara</creator><creatorcontrib>Ricci, Costantino ; Dika, Emi ; Di Nanni, Doriana Donatella ; Zannetti, Guido ; Lambertini, Martina ; Corti, Barbara</creatorcontrib><description>Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis.</description><identifier>ISSN: 0065-1281</identifier><identifier>EISSN: 1618-0372</identifier><identifier>DOI: 10.1016/j.acthis.2019.06.002</identifier><identifier>PMID: 31230705</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell - classification ; Carcinoma, Squamous Cell - diagnosis ; Carcinoma, Squamous Cell - metabolism ; Carcinoma, Squamous Cell - pathology ; Clear-cell squamous cell carcinoma ; Diagnosis, Differential ; E2F6 Transcription Factor - metabolism ; Female ; Humans ; Immunohistochemistry ; Keratin-7 - metabolism ; Male ; Neoplasm Proteins - metabolism ; Skin Neoplasms - classification ; Skin Neoplasms - diagnosis ; Skin Neoplasms - metabolism ; Skin Neoplasms - pathology ; Tricholemmal carcinoma</subject><ispartof>Acta histochemica, 2019-08, Vol.121 (6), p.765-767</ispartof><rights>2019 Elsevier GmbH</rights><rights>Copyright © 2019 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</citedby><cites>FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31230705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ricci, Costantino</creatorcontrib><creatorcontrib>Dika, Emi</creatorcontrib><creatorcontrib>Di Nanni, Doriana Donatella</creatorcontrib><creatorcontrib>Zannetti, Guido</creatorcontrib><creatorcontrib>Lambertini, Martina</creatorcontrib><creatorcontrib>Corti, Barbara</creatorcontrib><title>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</title><title>Acta histochemica</title><addtitle>Acta Histochem</addtitle><description>Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma, Squamous Cell - classification</subject><subject>Carcinoma, Squamous Cell - diagnosis</subject><subject>Carcinoma, Squamous Cell - metabolism</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Clear-cell squamous cell carcinoma</subject><subject>Diagnosis, Differential</subject><subject>E2F6 Transcription Factor - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Keratin-7 - metabolism</subject><subject>Male</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Skin Neoplasms - classification</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - metabolism</subject><subject>Skin Neoplasms - pathology</subject><subject>Tricholemmal carcinoma</subject><issn>0065-1281</issn><issn>1618-0372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9UcuO1DAQjBCIHRb-AKE-cklo23nMXECj0fKQFnGBs9VxOoyHJJ61nUX7c3wbzmbZI6dWuavcXV1Z9lpgIVDU704FmXi0oZAodgXWBaJ8km1ELbY5qkY-zTaIdZULuRUX2YsQToi4QyWfZxdKSIUNVpvsz8HNQwdXX_dAUwfmLrpf7CnaCRpoGebA_TxAgp0N6fXnbMMxFYjemqMbeBxpAEPe2MmNBL13I5iByeeGhwHCzUyjmwPco0feB9gnEBgCe8thlbnZQ8dn8nHkKd7vQ9Cmfg-eby3_BtdDPDIMNi47zp5fZs96GgK_eqiX2Y-PV98Pn_Prb5--HPbXuVG1jDm3omJMZ1OmKuueVCtMXTeNIqxIKdwJllvGVkrTERvVSUNIZJYO8U6qy-zt-u_Zu5uZQ9SjDYslmji501KWtSylKneJWq5U410Innt99nYkf6cF6iU5fdJrcnpJTmOtU3JJ9uZhwtyO3D2K_kWVCO9XAief6RpeB2N5MtxZzybqztn_T_gLfHOveA</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Ricci, Costantino</creator><creator>Dika, Emi</creator><creator>Di Nanni, Doriana Donatella</creator><creator>Zannetti, Guido</creator><creator>Lambertini, Martina</creator><creator>Corti, Barbara</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190801</creationdate><title>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</title><author>Ricci, Costantino ; Dika, Emi ; Di Nanni, Doriana Donatella ; Zannetti, Guido ; Lambertini, Martina ; Corti, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma, Squamous Cell - classification</topic><topic>Carcinoma, Squamous Cell - diagnosis</topic><topic>Carcinoma, Squamous Cell - metabolism</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Clear-cell squamous cell carcinoma</topic><topic>Diagnosis, Differential</topic><topic>E2F6 Transcription Factor - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Keratin-7 - metabolism</topic><topic>Male</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Skin Neoplasms - classification</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - metabolism</topic><topic>Skin Neoplasms - pathology</topic><topic>Tricholemmal carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ricci, Costantino</creatorcontrib><creatorcontrib>Dika, Emi</creatorcontrib><creatorcontrib>Di Nanni, Doriana Donatella</creatorcontrib><creatorcontrib>Zannetti, Guido</creatorcontrib><creatorcontrib>Lambertini, Martina</creatorcontrib><creatorcontrib>Corti, Barbara</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta histochemica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ricci, Costantino</au><au>Dika, Emi</au><au>Di Nanni, Doriana Donatella</au><au>Zannetti, Guido</au><au>Lambertini, Martina</au><au>Corti, Barbara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</atitle><jtitle>Acta histochemica</jtitle><addtitle>Acta Histochem</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>121</volume><issue>6</issue><spage>765</spage><epage>767</epage><pages>765-767</pages><issn>0065-1281</issn><eissn>1618-0372</eissn><abstract>Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>31230705</pmid><doi>10.1016/j.acthis.2019.06.002</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0065-1281 |
ispartof | Acta histochemica, 2019-08, Vol.121 (6), p.765-767 |
issn | 0065-1281 1618-0372 |
language | eng |
recordid | cdi_proquest_miscellaneous_2246242349 |
source | ScienceDirect Journals |
subjects | Aged Aged, 80 and over Carcinoma, Squamous Cell - classification Carcinoma, Squamous Cell - diagnosis Carcinoma, Squamous Cell - metabolism Carcinoma, Squamous Cell - pathology Clear-cell squamous cell carcinoma Diagnosis, Differential E2F6 Transcription Factor - metabolism Female Humans Immunohistochemistry Keratin-7 - metabolism Male Neoplasm Proteins - metabolism Skin Neoplasms - classification Skin Neoplasms - diagnosis Skin Neoplasms - metabolism Skin Neoplasms - pathology Tricholemmal carcinoma |
title | Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T19%3A51%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Could%20EMA%20and%20cytokeratin%207%20be%20useful%20in%20distinguishing%20tricholemmal%20carcinoma%20from%20clear-cell%20squamous%20cell%20carcinoma?%20A%20case%20series%20from%20our%20department%20and%20a%20brief%20review%20of%20the%20literature&rft.jtitle=Acta%20histochemica&rft.au=Ricci,%20Costantino&rft.date=2019-08-01&rft.volume=121&rft.issue=6&rft.spage=765&rft.epage=767&rft.pages=765-767&rft.issn=0065-1281&rft.eissn=1618-0372&rft_id=info:doi/10.1016/j.acthis.2019.06.002&rft_dat=%3Cproquest_cross%3E2246242349%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2246242349&rft_id=info:pmid/31230705&rfr_iscdi=true |